2017 has been a year full of change for the pharmaceutical industry. One of the biggest challenges has been the implementation of serialization ahead of the European Falsified Medicines Directive (EU FMD) and the US Drug Supply Chain and Security Act (DSCSA).

In this interview with European Pharmaceutical Manufacturer, our director of corporate strategy, Dexter Tjoa, reflects on the opportunities and challenges that Tjoapack has experienced in 2017 and discusses which market trends have driven the CPO’s activity.

Read the full interview here: https://www.epmmagazine.com/opinion/sector-highlights-tjoapack-interview/